Late presenters to HIV care and treatment, identification of associated risk factors in HIV-1 infected Indian population

BMC Public Health

Volumn 10, Issue , 2010, Pages

  Mojumdar, Kamalika ^a   Vajpayee, Madhu ^a   Chauhan, Neeraj K ^a   Mendiratta, Sanjay ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ADOLESCENT; ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; CHILD; CROSS-SECTIONAL STUDY; DELAYED DIAGNOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFANT; MALE; MIDDLE AGED; PATIENT ATTITUDE; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; ANTI-RETROVIRAL AGENTS; CD4 LYMPHOCYTE COUNT; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DELAYED DIAGNOSIS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INDIA; INFANT; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 77954418934     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-10-416     Document Type: Article

References (27)

1. Model of HIV-1 disease progression based on virus-induced lymph node homing and homing-induced apoptosis of CD4 lymphocytes. D Kirschner GF Webb M Cloyd, J Acquir Immune Defic Syndr 2000 24 4 352 362 11015152
2. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. W Lang H Perkins RE Anderson R Royce N Jewell W Winkelstein Jr, J Acquir Immune Defic Syndr 1989 2 1 63 69 2783971
3. Understanding delay to medical care for HIV infection: the long-term non-presenter. JH Samet KA Freedberg JB Savetsky LM Sullivan MD Stein, AIDS 2001 15 1 77 85 10.1097/00002030-200101050-00012 11192871
4. HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries? D Morgan C Mahe B Mayanja JM Okongo R Lubega JA Whitworth, AIDS 2002 16 4 597 603 10.1097/00002030-200203080-00011 11873003
5. Fighting against AIDS: the Brazilian experience. GC Levi MA Vitoria, AIDS 2002 16 18 2373 2383 10.1097/00002030-200212060-00001 12461410
6. HIV testing patterns: where, why, and when were persons with AIDS tested for HIV? PM Wortley SY Chu T Diaz JW Ward B Doyle AJ Davidson PJ Checko M Herr L Conti SA Fann,, et al. AIDS 1995 9 5 487 492 7639974
7. Late presenters in the era of highly active antiretroviral therapy: uptake of and responses to antiretroviral therapy. CA Sabin CJ Smith H Gumley G Murphy FC Lampe AN Phillips B Prinz M Youle MA Johnson, AIDS 2004 18 16 2145 2151 10.1097/00002030-200411050-00006 15577647
8. Meta-analysis of high-risk sexual behavior in persons aware and unaware they are infected with HIV in the United States: implications for HIV prevention programs. G Marks N Crepaz JW Senterfitt RS Janssen, J Acquir Immune Defic Syndr 2005 39 4 446 453 10.1097/01.qai.0000151079.33935.79 16010168
9. Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. A Zolopa J Andersen W Powderly A Sanchez I Sanne C Suckow E Hogg L Komarow, PLoS One 2009 4 5 5575 10.1371/journal.pone.0005575 19440326
10. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. SD Lawn L Myer LG Bekker R Wood, AIDS 2007 21 3 335 341 10.1097/QAD. 0b013e328011efac 17255740
11. - 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. From the Centers for Disease Control and Prevention, JAMA 1993 269 6 729 730 10.1001/jama.269.6.729 8093740
12. - 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. From the Centers for Disease Control and prevention, JAMA 1993 269 4 460 10.1001/jama.269.4.460
13. One disease, two epidemics - AIDS at 25. KA Sepkowitz, N Engl J Med 2006 354 23 2411 2414 10.1056/NEJMp068084 16760440
14. Discordant responses to potent antiretroviral treatment in previously naive HIV-1-infected adults initiating treatment in resource-constrained countries: the antiretroviral therapy in low-income countries (ART-LINC) collaboration. SH Tuboi MW Brinkhof M Egger RA Stone P Braitstein D Nash E Sprinz F Dabis LH Harrison M Schechter, J Acquir Immune Defic Syndr 2007 45 1 52 59 10.1097/QAI.0b013e318042e1c3 17460471
15. Delayed diagnosis of HIV infection and late initiation of antiretroviral therapy in the Swiss HIV Cohort Study. M Wolbers HC Bucher H Furrer M Rickenbach M Cavassini R Weber P Schmid E Bernasconi B Hirschel M Battegay, HIV Med 2008 9 6 397 405 10.1111/j.1468-1293.2008.00566.x 18410354
16. Determinants of delayed diagnosis of HIV infection in France, 1993-1995. E Couturier V Schwoebel C Michon JB Hubert MC Delmas P Morlat F Boue AM Simonpoli F Dabis JB Brunet, AIDS 1998 12 7 795 800 10.1097/00002030-199807000- 00016 9619812
17. Correlates of late HIV diagnosis: implications for testing policy. C Delpierre R Dray-Spira L Cuzin B Marchou P Massip T Lang F Lert, Int J STD AIDS 2007 18 5 312 317 10.1258/095646207780749709 17524190 (Pubitemid 351739001)
18. Predictors of delayed HIV diagnosis in a recently diagnosed cohort. JK Mayben JR Kramer MA Kallen L Franzini DR Lairson TP Giordano, AIDS Patient Care STDS 2007 21 3 195 204 10.1089/apc.2006.0097 17428187
19. Factors related to delayed diagnosis of HIV infection in southeastern France. EVALVIH group. M Rotily L Bentz C Pradier Y Obadia P Cavailler, Int J STD AIDS 2000 11 8 531 535 10.1258/0956462001916272 10990338
20. Medical checkups: who does not get them? D Culica J Rohrer M Ward P Hilsenrath P Pomrehn, Am J Public Health 2002 92 1 88 91 10.2105/AJPH.92.1.88 11772768
21. Gender differences in health care access indicators in an urban, low-income community. C Merzel, Am J Public Health 2000 90 6 909 916 10.2105/AJPH.90.6.909 10846508
22. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. PJ Easterbrook LM Yu E Goetghebeur F Boag K McLean B Gazzard, AIDS 2000 14 5 561 571 10.1097/00002030-200003310-00012 10780719
23. Delayed presentation and late testing for HIV: demographic and behavioral risk factors in a multicenter study in Italy. E Girardi MS Aloisi C Arici P Pezzotti D Serraino R Balzano G Vigevani F Alberici M Ursitti M D'Alessandro,, et al. J Acquir Immune Defic Syndr 2004 36 4 951 959 10.1097/00126334-200408010- 00009 15220702
24. Heterosexual men and women with HIV test positive at a later stage of infection than homo- or bisexual men. K Manavi A McMillan M Ogilvie G Scott, Int J STD AIDS 2004 15 12 811 814 10.1258/0956462042563585 15601487
25. Time to initiating highly active antiretroviral therapy among HIV-infected injection drug users. DD Celentano N Galai AK Sethi NG Shah SA Strathdee D Vlahov JE Gallant, AIDS 2001 15 13 1707 1715 10.1097/00002030- 200109070-00015 11546947 (Pubitemid 32918126)
26. Late HIV diagnosis and determinants of progression to AIDS or death after HIV diagnosis among injection drug users, 33 US States, 1996-2004. A Grigoryan HI Hall T Durant X Wei, PLoS One 2009 4 2 4445 10.1371/journal.pone.0004445 19214229
27. Limited effect of highly active antiretroviral therapy among HIV-positive injecting drug users on the population level. LC van Asten F Boufassa V Schiffer RP Brettle JR Robertson I Hernandez Aguado J McMenamin R Zangerle A Fontanet RA Coutinho,, et al. Eur J Public Health 2003 13 4 347 349 10.1093/eurpub/13.4.347 14703322